The Illusion of Care: New Evidence Reveals Widespread ‘Ghost Networks’ in Mental Healthcare on October 22, 2026 Posted by
The Sovereignty of Silicon: Why the Future of Intelligence is Being Built in the Underground on October 22, 2026 Posted by
The 2025–2030 Dietary Guidelines: A Blueprint for Health or a Recipe for Confusion? on October 22, 2026 Posted by
Beyond Mental Health: Psilocybin Shows Promise in Mitigating Biological Markers of Parkinson’s Disease on October 22, 2026 Posted by
CMS Launches Aggressive Crackdown on New York Social Adult Day Care Fraud on October 22, 2026 Posted by
The Silent Epidemic: Stroke Rates Surge Among Younger Adults, Challenging Traditional Medical Wisdom on October 22, 2026 Posted by
The Battle for Bodily Autonomy: Idaho’s High-Stakes Referendum on Abortion Rights on October 22, 2026 Posted by
The Illusion of Care: New Evidence Reveals Widespread ‘Ghost Networks’ in Mental Healthcare on October 22, 2026 Posted by
The Sovereignty of Silicon: Why the Future of Intelligence is Being Built in the Underground on October 22, 2026 Posted by
The 2025–2030 Dietary Guidelines: A Blueprint for Health or a Recipe for Confusion? on October 22, 2026 Posted by
Beyond Mental Health: Psilocybin Shows Promise in Mitigating Biological Markers of Parkinson’s Disease on October 22, 2026 Posted by
Posted in Sleep Health Advancing the Orexin Frontier: Breakthrough Study Validates Alixorexton for Narcolepsy Type 1 on September 20, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: The Promise of Alixorexton on September 12, 2026
Posted in Sleep Health A New Frontier in Sleep Medicine: Promising Phase 2 Results for Alixorexton in Narcolepsy Type 1 on September 4, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: The Potential of Alixorexton on August 27, 2026
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Extension Study on August 10, 2026
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Study on August 2, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: Alkermes’ Alixorexton Shows Sustained Efficacy in Long-Term Clinical Study on July 25, 2026
Posted in Medical Innovations The Orexin Frontier: How Alkermes Is Positioning Its "Alixorexton" to Disrupt the Sleep Medicine Landscape on June 27, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
